Pharmacokinetics and Pharmacodynamics Practice Questions

Q: What does the term 'tolerance' refer to in pharmacology?

Decreased effect of drug on the same dose. ***Decreased effect of drug on the same dose*** - **Tolerance** is a state in which the body's response to a drug is **reduced** over time, requiring higher doses to achieve the same effect. - This phenomenon often develops with **repeated exposure** to a drug, leading to a need for dose escalation. *Increased effect of drug on the same dose* - This describes **sensitization** or **reverse tolerance**, where the body becomes more responsive to the drug over time, which is the opposite of tolerance. - It is not a characteristic feature of pharmacological tolerance. *Same effect at lower doses* - This would imply an **increased sensitivity** to the drug, meaning that less drug is needed to achieve the desired effect. - This is contrary to the definition of tolerance, which requires higher doses for the same effect. *No effect* - While extreme tolerance can lead to a point where a drug has minimal or no clinical effect at standard doses, "no effect" itself is not the primary definition of tolerance. - Tolerance refers to the gradual **reduction in effect**, rather than an immediate absence of effect.

Q: At toxic doses, zero-order kinetics is seen in which of the following substances?

Phenytoin. ***Phenytoin*** - **Phenytoin** exhibits **zero-order kinetics** at toxic (saturating) doses because its metabolic enzymes become saturated, leading to a constant amount of drug eliminated per unit time rather than a constant fraction - This property makes its plasma concentration disproportionately increase with small dose adjustments once the enzymes are saturated, greatly increasing the risk of **toxicity** - Phenytoin is the **classic example** of capacity-limited metabolism due to saturation of hepatic enzymes (CYP2C9 and CYP2C19) *Penicillin* - Penicillin generally follows **first-order kinetics**, meaning a constant fraction of the drug is eliminated per unit time, and its elimination rate is proportional to its concentration - It is not commonly associated with zero-order kinetics even at higher doses, as its elimination pathways (renal excretion and metabolism) are typically not saturated within therapeutic or moderately toxic ranges *Valproate* - Valproate primarily follows **first-order kinetics** within its therapeutic range, with its elimination rate dependent on the drug concentration - While it can exhibit non-linear kinetics at very high concentrations due to protein binding saturation and enzyme saturation, it is less commonly cited as a classic example of zero-order kinetics compared to phenytoin *Carbamazepine* - Carbamazepine follows **first-order kinetics** within its therapeutic window - It undergoes **autoinduction** of its own metabolism, meaning that with continued dosing, its metabolic enzymes become more active, leading to increased elimination over time rather than saturation-induced zero-order kinetics

Q: What is the term used to describe the phenomenon where individuals with liver damage experience heightened effects from smaller doses of alcohol?

Reverse tolerance. ***Reverse tolerance*** - This term describes the phenomenon where individuals with **liver damage**, particularly due to chronic alcohol use, become more sensitive to the effects of alcohol. - The damaged liver is less efficient at metabolizing alcohol, leading to higher and longer-lasting blood alcohol concentrations, even with smaller doses. - This represents a **decrease in tolerance** (increased sensitivity), where smaller amounts of alcohol produce heightened effects due to impaired hepatic clearance. *Withdrawal* - **Withdrawal** refers to the set of symptoms that occur when a person who is physically dependent on a substance, like alcohol, stops or significantly reduces their intake. - It is characterized by symptoms such as tremors, seizures, and delirium, and is distinct from the **heightened effects of alcohol** from a small dose. *Mellanby phenomenon* - The **Mellanby phenomenon** describes the observation that the effects of alcohol are more pronounced when blood alcohol levels are rising compared to when they are falling, even if the absolute blood alcohol concentration is the same. - This relates to the acute dynamics of alcohol's effect on the brain, not to chronic liver damage increasing sensitivity to small doses. *Cross tolerance* - **Cross tolerance** occurs when an individual develops tolerance to one drug, and this tolerance extends to another, pharmacologically similar drug, often due to shared metabolic pathways or receptor systems. - It does not describe an increased sensitivity to the original substance due to organ damage, but rather a reduced response to a different substance.

Q: Alkaline diuresis is done for which of the following drugs?

Phenobarbitone. ***Phenobarbitone*** - **Phenobarbitone** is a weak acid, and its elimination can be enhanced by **alkaline diuresis**. - By increasing the pH of urine, **ionization** of the drug increases, reducing its reabsorption in the renal tubules and promoting excretion. *Morphine* - **Morphine** is an opioid analgesic that is largely metabolized in the liver and primarily excreted as **glucuronide conjugates** in the urine; alkaline diuresis is not a primary method for its elimination. - Although morphine is a **weak base**, its excretion is not significantly affected by alteration of urine pH because it is primarily eliminated through hepatic metabolism and conjugation rather than pH-dependent renal excretion. *Amphetamine* - **Amphetamine** is a weak base, and its elimination is enhanced by **acidic diuresis**, which increases its ionization in the urine. - **Alkaline diuresis** would *decrease* its excretion by promoting its reabsorption in the renal tubules. *Atropine* - **Atropine** is an anticholinergic drug with both renal and hepatic elimination, but its excretion is not significantly altered by **alkaline diuresis**. - Its elimination is influenced by its metabolism and renal excretion of unchanged drug, but not substantially by urinary pH manipulation for therapeutic purposes.

Q: An acidic drug with a pKa value of 4.5 has what percentage of ionized drug at a pH of 3.5?

10%. ***Correct: 10%*** - For an acidic drug, use the **Henderson-Hasselbalch equation**: **pH = pKa + log([ionized]/[unionized])** - Rearranging: **pH - pKa = log([ionized]/[unionized])** - Given **pH = 3.5** and **pKa = 4.5**: 3.5 - 4.5 = **-1** - Therefore: **log([ionized]/[unionized]) = -1** - This means: **[ionized]/[unionized] = 10^-1 = 0.1 = 1/10** - Percentage ionized = **1/(1+10) × 100% = 1/11 × 100% = 9.09%**, which rounds to **~10%** - **Key principle**: When pH < pKa for an acidic drug, the drug is predominantly **unionized** (protonated, HA form) *Incorrect: 1%* - This percentage would occur if **pH - pKa = -2** (e.g., pH 2.5 and pKa 4.5) - At this difference, [ionized]/[unionized] = 10^-2 = **1/100**, giving **~1% ionized** - Does not match the given values where the difference is only **-1** *Incorrect: 90%* - This represents the percentage of **unionized drug** in this scenario, not ionized - For an acidic drug to be **90% ionized**, the pH must be **significantly higher than pKa** (pH - pKa ≈ +1) - Since pH > pKa** (specifically when **pH - pKa ≥ +2**) - For example, at pH 6.5 and pKa 4.5, the drug would be **~99% ionized** - The given **pH of 3.5 is below the pKa**, so the drug is predominantly **unionized** (~91%), not ionized

Q: A 70 kg man was given a drug with a dose of 100 mg/kg body weight, twice daily. The half-life (t1/2) is 10 hours, the plasma concentration is 1.9 mg/mL, and the clearance is unknown. What is the clearance of this drug?

0.22 L/hr. ***0.22 L/hr*** - To calculate clearance at steady state, we use the formula: **Clearance (Cl) = Dose Rate / Css** (steady-state plasma concentration). - **Dose rate calculation**: 100 mg/kg × 70 kg × 2 doses/day = 14,000 mg/day = 583.33 mg/hr - **Converting plasma concentration**: 1.9 mg/mL = 1900 mg/L - **Clearance calculation**: Cl = 583.33 mg/hr ÷ 1900 mg/L = **0.307 L/hr** - **Note**: The calculated value (0.307 L/hr) does not exactly match any option. The marked answer (0.22 L/hr) is the closest approximation among the given choices. This discrepancy may arise from rounding in the original question parameters or implicit assumptions about bioavailability/volume of distribution. *0.02 L/hr* - This value is approximately 15 times lower than the calculated clearance. - Such low clearance would result in much higher plasma concentrations or require significantly lower dosing. *20 liter/hr* - This clearance is approximately 65 times higher than calculated, representing an unrealistically high value for this scenario. - Such high clearance would result in very low plasma concentrations unless extremely high doses were administered. *K is 0.0693* - This represents the **elimination rate constant (k)**, calculated as k = 0.693/t1/2 = 0.693/10 hr = 0.0693 hr⁻¹. - While mathematically correct for k, the question specifically asks for **clearance**, not the elimination rate constant. - Clearance is related to k by: Cl = k × Vd (volume of distribution).

Q: MDR gene acts by what mechanism?

Causes efflux of drug. ***Causes efflux of drug*** - The **MDR gene** (multidrug resistance gene) encodes for **P-glycoprotein**, an ATP-dependent efflux pump. - This pump actively **transports drugs out of the cell**, reducing their intracellular concentration and effectiveness. *Inhibit drug activation* - This mechanism is associated with enzymes like **CYP450 isoenzymes** or **esterases** that metabolize prodrugs into their active forms. - The MDR gene and its product, P-glycoprotein, are efflux pumps and do not directly inhibit drug activation. *Inhibit intracellular DNA synthesis* - This is the mechanism of action for certain classes of drugs, such as **antimetabolites** (e.g., methotrexate) or **nucleoside analogs**. - The MDR gene's role is in drug transport, not in interfering with DNA synthesis itself. *Inhibit DNA repair* - Some chemotherapeutic agents, like **PARP inhibitors**, work by preventing cells from repairing DNA damage, leading to apoptosis. - While related to drug action, this is not the primary mechanism by which the MDR gene confers resistance; instead, it reduces drug exposure to DNA targets.

Q: Which of the following is an example of a prodrug?

Levodopa. ***Levodopa is a prodrug that converts to dopamine.*** - A **prodrug** is an inactive precursor of a drug that is converted into its active form within the body. - **Levodopa** is converted to the active neurotransmitter **dopamine** in the brain, making it effective for Parkinson's disease. *Primidone is an anticonvulsant with active metabolites.* - While Primidone has **active metabolites** (phenobarbital and phenylethylmalonamide), the parent drug itself also possesses significant **anticonvulsant activity**, meaning it is not an inactive precursor. - A true prodrug is therapeutically inactive until metabolized. *Digitoxin is a cardiac glycoside that acts directly.* - **Digitoxin** is a cardiac glycoside that directly inhibits the **Na+/K+-ATPase pump**, exerting its therapeutic effect without requiring conversion to an active metabolite. - It does not undergo enzymatic conversion to an active form to produce its primary action. *Amitriptyline is an antidepressant that acts directly.* - **Amitriptyline** is a **tricyclic antidepressant** that directly inhibits the reuptake of norepinephrine and serotonin. - While it is metabolized to an active metabolite (nortriptyline), Amitriptyline itself is **pharmacologically active** as the parent drug.

Q: Which drug exhibits zero-order kinetics at high doses?

Phenytoin. ***Phenytoin*** - At **high doses**, the metabolic enzymes for phenytoin become saturated, leading to **zero-order kinetics** where a constant amount of drug is eliminated per unit time, regardless of concentration. - This saturation can result in a disproportionate increase in plasma concentration with small dose increases, making **phenytoin toxicity** a significant concern. *Propranolol* - Generally follows **first-order kinetics** within its therapeutic dose range, meaning a constant *fraction* of the drug is eliminated per unit time. - Its elimination rate is **concentration-dependent** at typical doses. *Amiloride* - This diuretic is primarily eliminated unchanged by the kidneys and follows **first-order kinetics**. - Its elimination is proportional to its plasma concentration. *Lithium* - Primarily eliminated renally and exhibits **first-order kinetics**, with its elimination rate proportional to its concentration. - It has a **narrow therapeutic index** but its elimination profile does not switch to zero-order at high doses.

Question 1

What does the term 'tolerance' refer to in pharmacology?

Accepted Answer

Decreased effect of drug on the same dose

Answer

Increased effect of drug on the same dose

Answer

Same effect at lower doses

Answer

No effect

Question 2

At toxic doses, zero-order kinetics is seen in which of the following substances?

Accepted Answer

Phenytoin

Answer

Valproate

Answer

Carbamazepine

Answer

Penicillin

Question 3

Which of the following describes the first-pass metabolism?

Accepted Answer

Drug given orally is metabolized by the liver before entering the circulation.

Answer

Drug given intravenously bypasses the liver initially.

Answer

Gastric acids primarily affect the stability of drugs.

Answer

Absorption of a drug occurs in the intestines.

Question 4

What is the term used to describe the phenomenon where individuals with liver damage experience heightened effects from smaller doses of alcohol?

Accepted Answer

Reverse tolerance

Answer

Withdrawal

Answer

Mellanby phenomenon

Answer

Cross tolerance

Question 5

Alkaline diuresis is done for which of the following drugs?

Accepted Answer

Phenobarbitone

Answer

Morphine

Answer

Amphetamine

Answer

Atropine

Question 6

An acidic drug with a pKa value of 4.5 has what percentage of ionized drug at a pH of 3.5?

Accepted Answer

10%

Answer

1%

Answer

90%

Answer

99%

Question 7

A 70 kg man was given a drug with a dose of 100 mg/kg body weight, twice daily. The half-life (t1/2) is 10 hours, the plasma concentration is 1.9 mg/mL, and the clearance is unknown. What is the clearance of this drug?

Accepted Answer

0.22 L/hr

Answer

20 liter/hr

Answer

K is 0.0693

Answer

0.02 L/hr

Question 8

MDR gene acts by what mechanism?

Accepted Answer

Causes efflux of drug

Answer

Inhibit drug activation

Answer

Inhibit intracellular DNA synthesis

Answer

Inhibit DNA repair

Question 9

Which of the following is an example of a prodrug?

Accepted Answer

Levodopa

Answer

Primidone

Answer

Digitoxin

Answer

Amitriptyline

Question 10

Which drug exhibits zero-order kinetics at high doses?

Accepted Answer

Phenytoin

Answer

Propranolol

Answer

Amiloride

Answer

Lithium

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?